Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-01-23 @ 9:26 PM
Study NCT ID:
NCT06537050
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-08-05
First Post:
2024-07-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects
Sponsor:
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Organization: